Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results
PRNewswire (Wed, 18-Mar 6:50 AM ET)
PRNewswire (Wed, 11-Mar 6:50 AM ET)
Globe Newswire (Mon, 9-Mar 8:30 AM ET)
Globe Newswire (Mon, 9-Mar 6:00 AM ET)
Ellomay Capital Announces Changes in its Principal Shareholders and Board Composition
Globe Newswire (Wed, 4-Mar 4:32 PM ET)
Market Chameleon (Mon, 2-Feb 6:09 AM ET)
Market Chameleon (Fri, 30-Jan 6:09 AM ET)
Globe Newswire (Fri, 30-Jan 9:47 AM ET)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Protalix Biotherapeutics (De) trades on the AMEX stock market under the symbol PLX.
As of April 9, 2026, PLX stock price climbed to $2.28 with 910,242 million shares trading.
PLX has a beta of 1.36, meaning it tends to be more sensitive to market movements. PLX has a correlation of 0.07 to the broad based SPY ETF.
PLX has a market cap of $183.70 million. This is considered a Micro Cap stock.
Last quarter Protalix Biotherapeutics (De) reported $9 million in Revenue and -$.06 earnings per share. This fell short of revenue expectation by $-5 million and missed earnings estimates by -$.07.
In the last 3 years, PLX traded as high as $3.55 and as low as $.82.
The top ETF exchange traded funds that PLX belongs to (by Net Assets): IWM, IWO, VTWO, DFAS, IWC.
PLX has underperformed the market in the last year with a return of 0.0%, while SPY returned +38.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PLX shares. However, PLX has outperformed the market in the last 3 month and 2 week periods, returning +14.0% and +5.6%, while SPY returned -1.1% and +3.5%, respectively. This indicates PLX has been having a stronger performance recently.
PLX support price is $2.17 and resistance is $2.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLX shares will trade within this expected range on the day.
